Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure

QR Code

Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure

Aim. To compare effectiveness of carvedilol as monotherapy and in combination with digoxin for heart rate (HR) control in patients with persistent atrial fibrillation (AF) and chronic heart failure (CHF). Material and methods. In total, 45 men and women, aged 42-77 years, with persistent AF and NYHA...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. N. Tereshchenko, N. G. Chuich, M. N. Morozova, A. G. Kochetkov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atrial fibrillation chronic heart failure beta-adrenoreactivity carvedilol digoxin
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1582
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bisoprolol and sotalol for maintaining sinus rhythm in patients with paroxysmal atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2005-12-01)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. F. Zadvorev, et al.
Published: (2018-05-01)

OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS
by: S. F. Zadvorev, et al.
Published: (2018-07-01)

Digoxin toxicity with therapeutic serum digoxin concentrations
by: J. Graafsma, et al.
Published: (2025-12-01)

New perspectives of recurrent atrial fibrillation prevention in coronary heart disease patients
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)

THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2017-12-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

Association of polymorphic variants of ADRB1 gene with contractile myocardial dysfunction and erythrocyte adrenoreactivity in patients with rhythm disorders
by: S. A. Afanasiev, et al.
Published: (2019-08-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Atrial fibrillation after heart transplantation
by: M. Kh. Lepshokova, et al.
Published: (2018-03-01)

THE EFFECTIVENESS OF CARVEDILOL AND EPROSARTAN IN PATIENTS WITH METABOLIC SYNDROME AND CHRONIC HEART FAILURE
by: R. L. Dashnamirov
Published: (2014-04-01)

UNEXPECTED DIFFICULTIES IN LONG PERSISTING ATRIAL FIBRILLATION TREATMENT
by: N. Yu. Mironov, et al.
Published: (2015-11-01)

Glycoprotein P pharmacogenetic assessment role in digoxin pharmacotherapy individualization: a new approach for an old problem
by: D. A. Sychev, et al.
Published: (2006-08-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Long-term carvedilol therapy effects on left ventricular remodeling and glycemia in patients with chronic heart failure and Type 2 diabetes mellitus
by: R. R. Samedov, et al.
Published: (2008-02-01)

Evaluation of ST2 as an early marker of heart failure with a preserved left ventricular ejection fraction in patients with persistent atrial fibrillation
by: E. A. Polyanskaya, et al.
Published: (2020-02-01)

Heart failure and atrial fibrillation: updates and perspectives
by: V. N. Larina, et al.
Published: (2022-08-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure
by: V. V. Kirillova, et al.
Published: (2020-11-01)

ATRIAL FIBRILLATION AND HEART FAILURE: APPROACHES TO ANTITHROMBOTIC THERAPY
by: B. A. Tatarsky, et al.
Published: (2017-08-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Βeta-adrenergic receptor reactivity of erythrocyte membranes in patients with left or right atrial dilatation against the background of atrial fibrillation
by: E. F. Muslimova, et al.
Published: (2023-10-01)

Left heart remodeling as a risk factor for atrial fibrillation in patients after surgery of acquired heart defects
by: I. I. Averina, et al.
Published: (2023-08-01)

Atrial Fibrillation Associated with Anticancer Drugs
by: O. D. Ostroumova, et al.
Published: (2020-12-01)

Carvedilol therapy effects on structural and electric remodeling in chronic heart failure
by: E. V. Minakov, et al.
Published: (2008-02-01)

Role of catheter ablation in patients with heart failure and atrial fibrillation
by: Min-Su Jung, et al.
Published: (2025-07-01)

Stage surgical and catheter approach to the treatment of long-persistent atrial fibrillation
by: E. A. Artyukhina, et al.
Published: (2019-08-01)

PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE
by: I. V. Graifer, et al.
Published: (2016-01-01)

LABORATORY AND GENETIC PREDICTION OF THE RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH CORONARY HEART DISEASE
by: D. I. PANCHENKO, et al.
Published: (2017-05-01)

Predictors of Thrombus Dissolution in the Left Atrial Appendage in Patients with Persistent Nonvalvular Atrial Fibrillation
by: E. S. Mazur, et al.
Published: (2022-03-01)

Heart rate variability and trans-esophageal atrial stimulation data in predicting recurrent atrial fibrillation paroxysms
by: T. V. Setyn, et al.
Published: (2007-12-01)

ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES
by: E. I. Bambysheva, et al.
Published: (2016-01-01)

Role of Digoxin in Preventing Cigarette Smoke-Induced COPD via HIF-1&alpha; Inhibition in a Mouse Model
by: Zhang K, et al.
Published: (2025-05-01)

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS
by: A. R. Kiselev, et al.
Published: (2016-01-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
by: E. V. Kokhan, et al.
Published: (2021-07-01)

The role of inflammatory markers in atrial fibrillation: a review
by: S. V. Grigoryan, et al.
Published: (2012-10-01)